RE: Share price23 Sep 2021 13:38
Jeepers ok if need me to spell it out... Institutional investors will do due diligence and meet with the company and board and employ their own analysts to support their decision making. This provides more transparency for the market other than a house broker coming out with target prices and forecasts ( in this case changing the formula for valuations last year). So this in turn give more confidence to investors and greater accountability for the board. what we have hear is a situation where the board are not as accountable and hence we get promises, smoke and mirrors. The question remains, why aren't institutional investors piling in to a fast growing pharm services company? Why are retail investors his main audience. Your welcome